Literature DB >> 20803523

Phlorotannins from Ecklonia cava (Phaeophyceae): biological activities and potential health benefits.

Isuru Wijesekara1, Na Young Yoon, Se-Kwon Kim.   

Abstract

The importance of bioactive derivatives as functional ingredients has been well recognized due to their valuable health beneficial effects. Therefore, isolation and characterization of novel functional ingredients with biological activities from seaweeds have gained much attention. Ecklonia cava Kjellman is an edible seaweed, which has been recognized as a rich source of bioactive derivatives mainly, phlorotannins. These phlorotannins exhibit various beneficial biological activities such as antioxidant, anticancer, antidiabetic, anti-human immunodeficiency virus, antihypertensive, matrix metalloproteinase enzyme inhibition, hyaluronidase enzyme inhibition, radioprotective, and antiallergic activities. This review focuses on biological activities of phlorotannins with potential health beneficial applications in functional foods, pharmaceuticals, and cosmeceuticals.
Copyright © 2010 International Union of Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20803523     DOI: 10.1002/biof.114

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.113


  44 in total

Review 1.  From alga to omega; have we reached peak (fish) oil?

Authors:  Paul R Clayton; Szabolcs Ladi
Journal:  J R Soc Med       Date:  2015-09       Impact factor: 5.344

2.  Antitumor activity of a polysaccharide fraction from Laminaria japonica on U14 cervical carcinoma-bearing mice.

Authors:  Qingzhi Zhai; Xiuli Li; Yizhuo Yang; Ling Yu; Yuanqing Yao
Journal:  Tumour Biol       Date:  2013-08-08

3.  Application of response surface method to evaluate the cytotoxic potency of Ulva fasciata Delile, a marine macro alga.

Authors:  Mukesh Kumar Das; Prafulla Kumar Sahu; G Srinivasa Rao; K Mukkanti; L Silpavathi
Journal:  Saudi J Biol Sci       Date:  2014-02-19       Impact factor: 4.219

Review 4.  Neuroprotective effects of marine algae.

Authors:  Ratih Pangestuti; Se-Kwon Kim
Journal:  Mar Drugs       Date:  2011-05-10       Impact factor: 6.085

5.  Antitumor activity of a sulfated polysaccharide from Enteromorpha intestinalis targeted against hepatoma through mitochondrial pathway.

Authors:  Xuxia Wang; Ying Chen; Jingjie Wang; Zhenxiong Liu; Shuguang Zhao
Journal:  Tumour Biol       Date:  2013-10-02

6.  Phytochemical Analysis and Evaluation of the Antioxidant, Anti-Inflammatory, and Antinociceptive Potential of Phlorotannin-Rich Fractions from Three Mediterranean Brown Seaweeds.

Authors:  Amal Abdelhamid; Meriem Jouini; Haifa Bel Haj Amor; Zeineb Mzoughi; Mehdi Dridi; Rafik Ben Said; Abderrahman Bouraoui
Journal:  Mar Biotechnol (NY)       Date:  2018-01-18       Impact factor: 3.619

7.  Tasco®: a product of Ascophyllum nodosum enhances immune response of Caenorhabditis elegans against Pseudomonas aeruginosa infection.

Authors:  Saveetha Kandasamy; Wajahatullah Khan; Franklin Evans; Alan T Critchley; Balakrishnan Prithiviraj
Journal:  Mar Drugs       Date:  2012-01-11       Impact factor: 6.085

Review 8.  Beneficial effects of marine algal compounds in cosmeceuticals.

Authors:  Noel Vinay Thomas; Se-Kwon Kim
Journal:  Mar Drugs       Date:  2013-01-14       Impact factor: 5.118

9.  Polyphenol-Rich Fraction of Brown Alga Ecklonia cava Collected from Gijang, Korea, Reduces Obesity and Glucose Levels in High-Fat Diet-Induced Obese Mice.

Authors:  Eun Young Park; Eung Hwi Kim; Mi Hwi Kim; Young Wan Seo; Jung Im Lee; Hee Sook Jun
Journal:  Evid Based Complement Alternat Med       Date:  2012-07-12       Impact factor: 2.629

Review 10.  Antioxidant and Signal-Modulating Effects of Brown Seaweed-Derived Compounds against Oxidative Stress-Associated Pathology.

Authors:  Rahima Begum; Saurav Howlader; A N M Mamun-Or-Rashid; S M Rafiquzzaman; Ghulam Md Ashraf; Ghadeer M Albadrani; Amany A Sayed; Ilaria Peluso; Mohamed M Abdel-Daim; Md Sahab Uddin
Journal:  Oxid Med Cell Longev       Date:  2021-07-10       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.